Track topics on Twitter Track topics that are important to you
Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax Platform / Company Joins Global Race to Find Vaccine; Previous Data Support Potential of Immunovaccine's DepoVax Platform Against Other Major Health Threats, Including R
HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/03/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV) (OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today anno...
NewsTakeda Pharmaceutical Company Limited announced that it has dosed the first subject in a Phase 2b field efficacy trial of Takeda’s norovirus vaccine candidate, the only norovirus vaccine candid...
Osaka, Japan, June 20, 2016 – Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has dosed the first subject in a Phase 2b field efficacy trial of ...
TORONTO, May 5, 2016 /PRNewswire/ -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine candidates. Logo - http://photos.prnewswire.com/prnh/20160...
As the 69th World Health Assembly discusses progress on the Global Vaccine Action Plan, a new data visualization platform from the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloom...
The HPV vaccine has reduced rates of HPV, but what about the herd effect of the vaccine? Medscape Pediatrics
The short history of the HPV vaccine has been eventful. Will the first vaccine to prevent cancer survive this rocky patch? Medscape Family Medicine
Quadrivalent vaccine type HPV prevalence in young U.S. women has declined steeply even though vaccine coverage remains incomplete.
Factors, such as age, comorbidities, vaccine type, herd immunity, previous influenza exposure, and antigenic shift, may impact the immune response to the influenza vaccine, protection against circulat...
After publication of certain vaccine recommendations made by the Advisory Committee on Immunization Practices, several unexpected events have occurred during implementation of these recommendations. T...
Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and ...
Background Men who have sex with men (MSM), particularly HIV-infected MSM are disproportionately affected by HPV infection and associated disease. The HPV vaccine has potential to greatly reduce the b...
Observational studies have suggested that girls have higher mortality if their most recent immunization is an inactivated vaccine rather than a live vaccine. We therefore reanalyzed five randomized tr...